Plan B One-Step OTC Proposal Leaves Plaintiffs, Judge Korman Wary
This article was originally published in The Pink Sheet Daily
Executive Summary
The Center for Reproductive Rights and other plaintiffs suing FDA say the agency’s plan to approve only Teva’s Plan B One-Step for universal OTC sales, but not less-expensive generic emergency contraceptives, would not provide sufficient access for all women.